Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jul;14(7):e009811.
doi: 10.1161/CIRCEP.121.009811. Epub 2021 Jun 29.

Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study

Emilio Attena  1 , Stefano Albani  1   2 , Alberto Enrico Maraolo  3 , Mariano Mollica  4 , Annunziata De Rosa  5 , Raffaella Pisapia  3 , Giuseppe Fiorentino  4 , Roberto Parrella  5 , Sergio Severino, Vincenzo Russo  6
Affiliations
Observational Study

Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study

Emilio Attena et al. Circ Arrhythm Electrophysiol. 2021 Jul.
No abstract available

Keywords: COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir.

PubMed Disclaimer

References

    1. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et al. ; ACTT-1 Study Group Members. Remdesivir for the treatment of COVID-19 - Final Report. N Engl J Med. 2020; 383:1813–1826. doi: 10.1056/NEJMoa2007764 - PMC - PubMed
    1. Gubitosa JC, Kakar P, Gerula C, Nossa H, Finkel D, Wong K, Khatri M, Ali H. Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review. JACC Case Rep. 2020; 2:2260–2264. doi: 10.1016/j.jaccas.2020.08.025 - PMC - PubMed
    1. Italian Medicines Agency. Remdesivir nella terapia dei pazienti adulti con COVID-19. 24/11. 2020:1–6. Accessed March 3, 2021. https://www.aifa.gov.it/documents/20142/1123276/remdesivir_update01_24.1...
    1. Jorgensen SCJ, Kebriaei R, Dresser LD. Remdesivir: review of pharmacology, pre-clinical data, and emerging clinical experience for COVID-19. Pharmacotherapy. 2020; 40:659–671. doi: 10.1002/phar.2429 - PMC - PubMed

MeSH terms